These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 24394973

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation].
    Liu X, Li JX, Hu JZ, Shen Y, Wan R, Xiong QM, Zhou QQ, Xie JY, Jin JJ, Yan X, Yu JH, Hong K.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan 25; 45(1):39-43. PubMed ID: 28100344
    [Abstract] [Full Text] [Related]

  • 25. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B, Bagnall RD, Lam L, Ingles J, Turner C, Haan E, Davis A, Yang PC, Clancy CE, Sy RW, Semsarian C.
    Heart Rhythm; 2016 Aug 25; 13(8):1652-60. PubMed ID: 27157848
    [Abstract] [Full Text] [Related]

  • 26. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
    Laitinen PJ, Swan H, Kontula K.
    Eur J Hum Genet; 2003 Nov 25; 11(11):888-91. PubMed ID: 14571276
    [Abstract] [Full Text] [Related]

  • 27. Are RYR2 exon-3 deletions truly causative for non-compaction?
    Finsterer J, Stöllberger C.
    Europace; 2014 Dec 25; 16(12):1864. PubMed ID: 24728420
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alport syndrome. Molecular genetic aspects.
    Hertz JM.
    Dan Med Bull; 2009 Aug 25; 56(3):105-52. PubMed ID: 19728970
    [Abstract] [Full Text] [Related]

  • 31. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C, Campuzano O, Sarquella-Brugada G, Cesar S, Perez-Serra A, Coll M, Mademont I, Mates J, Del Olmo B, Iglesias A, Brugada J, Petersen V, Brugada R.
    Forensic Sci Int; 2017 Jan 25; 270():173-177. PubMed ID: 27988446
    [Abstract] [Full Text] [Related]

  • 32. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E, Belhassen B, Arad M, Bhuiyan ZA, Antzelevitch C, Rosso R, Fogelman R, Luria D, El-Ani D, Mannens MM, Viskin S, Eldar M, Wilde AA, Glikson M.
    Heart Rhythm; 2011 Oct 25; 8(10):1546-52. PubMed ID: 21699856
    [Abstract] [Full Text] [Related]

  • 33. Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation.
    Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, Rupp S, Müller A, Steen H, Ivandic BT, Ulmer HE, Kern M, Katus HA, Frey N.
    Cardiovasc Res; 2010 Jun 01; 86(3):452-60. PubMed ID: 20083571
    [Abstract] [Full Text] [Related]

  • 34. Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.
    Wangüemert F, Bosch Calero C, Pérez C, Campuzano O, Beltran-Alvarez P, Scornik FS, Iglesias A, Berne P, Allegue C, Ruiz Hernandez PM, Brugada J, Pérez GJ, Brugada R.
    Heart Rhythm; 2015 Jul 01; 12(7):1636-43. PubMed ID: 25814417
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ, Arya P, Will M, Haglund CM, Farley AL, Makielski JC, Ackerman MJ.
    Heart Rhythm; 2006 Jul 01; 3(7):800-5. PubMed ID: 16818210
    [Abstract] [Full Text] [Related]

  • 38. Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening.
    Roux-Buisson N, Gandjbakhch E, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Mansencal N, Delacretaz E, Cosnay P, Scanu P, Extramiana F, Keller D, Hidden-Lucet F, Trapani J, Fouret P, Frank R, Fressart V, Fauré J, Lunardi J, Charron P.
    Heart Rhythm; 2014 Nov 01; 11(11):1999-2009. PubMed ID: 25041964
    [Abstract] [Full Text] [Related]

  • 39. Postmortem genetic screening of SNPs in RyR2 gene in sudden unexplained nocturnal death syndrome in the southern Chinese Han population.
    Huang L, Liu C, Tang S, Su T, Cheng J.
    Forensic Sci Int; 2014 Feb 01; 235():14-8. PubMed ID: 24447446
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.